| Financial Year |
March 31 2023 |
| Monetary Funds |
660,959,901.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,900,135.56 |
| Accounts Receivable |
1,098,985,025.16 |
| Advances to Suppliers |
62,325,670.45 |
| Other Receivables |
44,801,814.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
883,079,061.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,603,256.60 |
| Other Current Assets |
13,478,370.72 |
| Total Current Assets |
3,006,389,700.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,512,953.41 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
285,611,574.18 |
| Under-construction Projects |
43,575,084.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,229,128.93 |
| R&D expenses |
-- |
| Goodwill |
60,120,319.48 |
| Long-Term Deferred and Prepaid Expenses |
39,098,648.20 |
| Deferred Income Tax Assets |
57,376,218.21 |
| Other Non-Current Assets |
18,653,516.00 |
| Sub-Total of Non-Current Assets |
799,933,081.27 |
| Total Assets |
3,806,322,781.91 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,207,236.37 |
| Accounts Payable |
954,857,783.76 |
| Accounts Received In Advance |
6,627,278.35 |
| Employee Compensation Payable |
17,375,059.57 |
| Taxes Payable |
28,162,356.04 |
| Interest Payable |
-- |
| Dividend Payable |
4,079,788.53 |
| Other payables |
182,038,764.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,374,569.54 |
| Other Current Liabilities |
86,073,481.05 |
| Sub-Total of Current Liabilities |
1,772,375,314.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,046,024.47 |
| Deferred Income Tax Liabilities |
18,913,267.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
183,748,593.22 |
| Total Liabilities |
1,956,123,907.81 |
| Paid-In Capital(Or Share Stock) |
450,225,001.00 |
| Capital Surplus |
783,409,655.64 |
| Surplus Reserve |
72,750,012.51 |
| LESS:Treasury Stock |
97,389,477.60 |
| Undistributed Profits |
498,965,988.64 |
| Minority Stockholder's Interest |
134,836,155.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,715,362,719.08 |
| Owner's Equity（Stockholder's Equity） |
1,850,198,874.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,806,322,781.91 |
